232 related articles for article (PubMed ID: 23787697)
1. Binding of bovine T194A PrP(C) by PrP(Sc)-specific antibodies: potential implications for immunotherapy of familial prion diseases.
Madampage CA; Määttänen P; Marciniuk K; Brownlie R; Andrievskaia O; Potter A; Cashman NR; Lee JS; Napper S
Prion; 2013; 7(4):301-11. PubMed ID: 23787697
[TBL] [Abstract][Full Text] [Related]
2. PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 mice.
Määttänen P; Taschuk R; Ross L; Marciniuk K; Bertram L; Potter A; Cashman NR; Napper S
Prion; 2013; 7(5):434-9. PubMed ID: 24105298
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
4. Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP.
Yuan FF; Biffin S; Brazier MW; Suarez M; Cappai R; Hill AF; Collins SJ; Sullivan JS; Middleton D; Multhaup G; Geczy AF; Masters CL
Immunol Cell Biol; 2005 Dec; 83(6):632-7. PubMed ID: 16266315
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
6.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
7. Safety, specificity and immunogenicity of a PrP(Sc)-specific prion vaccine based on the YYR disease specific epitope.
Taschuk R; Marciniuk K; Määttänen P; Madampage C; Hedlin P; Potter A; Lee J; Cashman NR; Griebel PJ; Napper S
Prion; 2014; 8(1):51-9. PubMed ID: 24509522
[TBL] [Abstract][Full Text] [Related]
8. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
9. Methods and Protocols for Developing Prion Vaccines.
Marciniuk K; Taschuk R; Napper S
Methods Mol Biol; 2016; 1403():657-80. PubMed ID: 27076159
[TBL] [Abstract][Full Text] [Related]
10. Development of a multivalent, PrP(Sc)-specific prion vaccine through rational optimization of three disease-specific epitopes.
Marciniuk K; Määttänen P; Taschuk R; Airey TD; Potter A; Cashman NR; Griebel P; Napper S
Vaccine; 2014 Apr; 32(17):1988-97. PubMed ID: 24486363
[TBL] [Abstract][Full Text] [Related]
11. Development of antibody fragments for immunotherapy of prion diseases.
Campana V; Zentilin L; Mirabile I; Kranjc A; Casanova P; Giacca M; Prusiner SB; Legname G; Zurzolo C
Biochem J; 2009 Mar; 418(3):507-15. PubMed ID: 19000036
[TBL] [Abstract][Full Text] [Related]
12. Protein misfolding cyclic amplification of prions.
Saunders SE; Bartz JC; Shikiya RA
J Vis Exp; 2012 Nov; (69):. PubMed ID: 23168797
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells.
Handisurya A; Gilch S; Winter D; Shafti-Keramat S; Maurer D; Schätzl HM; Kirnbauer R
FEBS J; 2007 Apr; 274(7):1747-58. PubMed ID: 17313482
[TBL] [Abstract][Full Text] [Related]
14. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
Yam AY; Gao CM; Wang X; Wu P; Peretz D
PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
[TBL] [Abstract][Full Text] [Related]
15. Design and delivery of a cryptic PrP(C) epitope for induction of PrP(Sc)-specific antibody responses.
Hedlin PD; Cashman NR; Li L; Gupta J; Babiuk LA; Potter AA; Griebel P; Napper S
Vaccine; 2010 Jan; 28(4):981-8. PubMed ID: 19925901
[TBL] [Abstract][Full Text] [Related]
16. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
17. A Quick Method to Evaluate the Effect of the Amino Acid Sequence in the Misfolding Proneness of the Prion Protein.
Fernández-Borges N; Eraña H; Elezgarai SR; Harrathi C; Venegas V; Castilla J
Methods Mol Biol; 2017; 1658():205-216. PubMed ID: 28861792
[TBL] [Abstract][Full Text] [Related]
18. Prion protein self-peptides modulate prion interactions and conversion.
Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A
BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977
[TBL] [Abstract][Full Text] [Related]
19. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
20. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
